Domestic manufacturers welcome greater market access, urge careful monitoring of import dynamics and regulatory alignment India’s medical device manufacturers have voiced their support for the proposed India-UK Free Trade Agreement (FTA), citing expanded opportunities for global collaboration and technology transfer. However, industry stakeholders also stressed the
Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concernsIndia’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and
The Association of Indian Medical Device Industry (AiMeD) has raised strong objections to a recent notification issued on March 10, 2025, by the Commissionerate of Health, Medical Services & Medical Education, Government of Gujarat. The notification sets an unjust reimbursement structure, allocating ₹25,000 for USFDA-approved
Calls for Policy Reforms to Curb Unfair Import Practices and Boost Make-in-India Initiative in Medical Devices SectorThe Association of Indian Medical Device Industry (AiMeD), representing domestic manufacturers, has called upon the government to impose safeguard duties on imported medical devices to protect India’s burgeoning medical
In a major boost to India's medical technology sector, the country has begun domestic manufacturing of advanced medical devices, including CT scanners, MRI machines, and dialysis equipment, under the Production Linked Incentive (PLI) scheme. This initiative, introduced by the Government of India, aims to reduce
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial RevolutionVenus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone in workforce development by
India's medical device sector is witnessing transformative changes with recent government initiatives designed to propel the country into a global manufacturing hub for medical devices. Minister Naddaji, along with Minister of State Ms. Patel and Secretary of Pharmaceuticals Dr. Arunish Chawla, recently announced new incentives
Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma Private Limited (Lyfius Pharma)invested ₹2,500 crores in Penicillin-G (Pen-G) facilityCommercial production to ramp up in FY25, enhancing domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)Lyfius Pharma
PHD Chamber of Commerce and Industry organized conference on the classification of health products “Health Horizons: Defining the Future of Health Products” at PHD House, New Delhi. The event brought together key industry leaders and policymakers to discuss the future of health products in India.Dr.
The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics The grant emphasises the company’s commitment to driving innovation, entitles it to incentives for incremental sales of eligible pharmaceutical products Venus Remedies Ltd, one of India’s leading manufacturers of generic
